‘Life just changed.' How Miami doctors use tech to treat cancer and sickle cell
Technology is fueling the future of health in South Florida.
Lots of innovation is happening in the region. Medical students are using simulators to train. AI is targeting Alzheimer's, cancer and other health conditions. Elon Musk's brain chips are undergoing clinical trials in Miami.
Some of the emerging tech is already making a difference in patient care and is changing how doctors treat cancer, strokes and genetic conditions like sickle cell disease. It's also helping boost quality of life for patients.
Ultrasounds target cancerous tumors
High-intensity ultrasounds are being used to liquefy cancerous tumors in the liver as part of a new pain-free treatment at Memorial Healthcare System, one of Broward's public hospital networks. It's one of the latest innovations helping doctors treat difficult and life-threatening conditions in South Florida, sometimes by assisting the body's own natural immune response.
The procedure 'is going to open the doors to really allow us to be more aggressive' against advanced cancers that have limited treatment options, said Dr. Omar Llaguna, a surgical oncologist with the Memorial Cancer Institute at Memorial Healthcare System.
The ultrasound tech will be used to target tumors in the liver, often caused from cancer that spread to the organ from the colon or other parts of the body. Invisible sound waves transcend the skin to'drill' into, and carve out, the cancerous tumor from the organ, the doctor said. Bubbles form and pop within the infected tissue, rupturing and destroying the tumor.
'It almost looks like a little hurricane underwater,' said Llaguna, who closely watches the procedure through a screen.
The destroyed tumor turns into a jelly-like liquid. Then it's time to let the body's immune system do its thing, absorbing and ridding itself of the unnecessary and extra fluid. No surgery, no chemotherapy, no radiation needed.
It 'destroys the tumor beyond recognition. ... It really opens up the opportunities for us to treat patients who normally would have needed invasive procedures but also treat patients who may not have been candidates for these procedures due to co-morbidities or other medical problems,' Llaguna said.
Memorial expects the FDA-approved technology, known as the Edison Histotripsy System, could help hundreds of cancer patients who are not eligible for surgery. Memorial plans to begin offering the treatment soon and is assessing several patients to ensure the treatment is right for them.
Llaguna said the ultrasound beams will first be used in combination with other treatments to target liver cancer and metastatic cancer that spread to the organ in patients not eligible for surgeries. The company behind the tech is hosting clinical trials to see whether it can be used to treat pancreatic, kidney and other cancers, too.
More affordable 3D-printed prosthetic
At Florida International University, 3D printing is helping to create more affordable kid-size prosthetics as part of a new at-home exercise program to help kids learn how to better manage everyday tasks.
'I know how costly' a traditional prosthetic is, said Amanda Thomas, clinical assistant professor for physical therapy at FIU. Her son was born without a right hand and is now using one of the 3D-printed prosthetics created at FIU's Miami Beach Urban Studios.
Prosthetics usually cost thousands and are made fit-to-order, with kids often needing new prosthetics for their growing body every one to two years. Some insurances may cover at least part of the prosthetic cost. Others may require patients to wait a certain amount of time before ordering a new prosthetic.
That means some families could be left with a hefty bill or priced out of giving their kids the option to explore what it's like to use a prosthetic, Thomas said.
That's where 3D-printing comes in.
Her 11-year-old son Hayden's 3D-printed yellow-colored hand prosthetic has helped him perform every-day activities more easily. He feels more confident in himself. Hayden, who loves playing soccer and other sports, has even used his prosthetic hand to help play tennis.
The cost of his 3D-printed hand: $30, she said.
'Seeing how he's progressed and going through this whole process is amazing. It's a wonderful feeling,' said Thomas.
Hayden, like other kids who were born without a part of their upper limb, will sometimes experience an uncomfortable hypersensitivity around their limb. It's a common reason why kids tend to not like using prosthetics, Thomas said.
That led Thomas and her doctor of physical therapy students to create an at-home exercise program to help kids like Hayden strengthen and desensitize their limbs and learn how to use the 3D-printed prosthetic.
The exercises use items families have around their home and requires the limb to be exposed to different sensations, including using shaving cream to write the alphabet and draw shapes, putting the limb in a bucket of rice, and create shapes with Play-Doh, according to Thomas.
Hayden's 3D-printed hand is 'body powered,' which means he has to use his limb to manipulate the hand. With the 3D-printed hand, Hayden would have to do a variety of repetitive exercises, including picking up and setting down an empty water bottle, learn how to open and close his hand, turn pages in a book, push blocks and wave.
After four weeks, his strength, sensitivity and coordination had improved, according to Thomas. She saw similar results with other kids. Her research, which was published in the Journal of Hand Therapy, has drawn global interest, according to FIU.
Thomas' team is now looking to build 3D-printed kid orthotics — devices that can help relieve pain associated with foot conditions — and custom made prosthetics. Families interested in getting a 3D-printed prosthetic or joining the at-home exercise program, can contact Thomas at amthomas@fiu.edu.
The future of gene therapy
At Miami-Dade's public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a patient's blood cells to lessen the effects of sickle cell disease, a painful blood disorder that can lead to life-threatening complications.
The inherited blood disorder deforms red blood cells, turning them into sickle-like shapes, which can get stuck in the bloodstream, preventing oxygen flow. The disease, which has no cure, is known to cause excruciating pain and fatigue, and can lead to serious complications, including strokes, lung problems and organ damage.
'I'm screaming the whole way to the hospital. That's how bad the pain is,' said Javarian Weatherspoon, 21, of the Orlando area, who has lived with sickle cell disease his entire life.
Weatherspoon grew up alongside his four siblings like any other child, going to school, and playing sports and video games. But he also saw hospital walls more than the average person.
He had his first surgery — the removal of his spleen — at age 2. At 7, the Make-A-Wish recipient and his family were gifted a trip to the Nickelodeon hotel in Orlando to celebrate his birthday and visit the theme parks. At 14, his gallbladder was removed. By 17, chronic pain led to monthly hospital visits.
One day, his blood pressure and hemoglobin levels dropped to dangerous levels.
'His doctor said, had we not brought him in, he probably would have died in his sleep,' said his mom Raheeda Fisher.
Now at 21, Weatherspoon became the first patient in South Florida to undergo a new gene therapy, part of a clinical trial by Beam Therapeutics to reduce the disease's symptoms. The therapy, known as Beam-101, is being administered by a medical team at Holtz Children's Hospital and the University of Miami Health System.
The trial utilizes 'base editing' to give scientists the ability to rewire the body's genes, similar to how a programmer will delete and input new code to fix a faulty computer program.
With gene editing, scientists are able to input code into the body's genes that tell it to stop producing the mutation that is causing the abnormal red blood cells. The new genes tell the body to produce a fetal form of hemoglobin, an oxygen-carrying protein found in normal shaped red blood cells. The goal is to help reduce a patient's symptoms.
'We're fixing very small parts of it so it's nothing like the science fiction' tech that turns people into super humans, said Dr. David Crawford, director of pediatric stem cell transplantation at UHealth and Holtz Children's. 'We're modifying a single gene to fix us a little problem. But it is an amazing thing.'
Crawford sees gene therapy as a useful alternative for patients like Weatherspoon who were not eligible for a bone marrow transplant due to damage from the disease.
Sickle cell disease affects about 100,000 people in the United States, the majority of which are non-Hispanic Black or African American, according to the U.S. Centers for Disease Control and Prevention. The condition usually worsens as patients age, with symptoms often making it difficult for patients to attend school or work, according to Jackson Health.
So far, about 13 patients have received the new gene therapy at select medical centers in the United States and Europe, according to the Miami hospital.
And Crawford has high hopes for the future of gene therapy and its use in treating sickle cell and other conditions. Federal regulators have already approved several gene therapies to help treat certain conditions, including blood disorders like sickle cell disease, neurological conditions like spinal muscular atrophy in kids, and cancers, including certain types of leukemias and lymphomas.
And advancements continue to be made. A Philadelphia baby who spent most of his life hospitalized with a rare and deadly genetic disease recently made headlines after doctors crafted a new personalized gene-editing treatment for him. The treatment seems to have worked and the baby was discharged from the hospital earlier this month, according to ABC News.
'My whole life just changed,' patient says
When Weatherspoon's doctor recommended he join the clinical trial in Miami, he and his mom were wary. But they decided to try it. Once doctors determined he was an eligible candidate, Weatherspoon and his family drove down to Miami. His stem cells were harvested in September — in a process similar to a 'prolonged blood draw' — and sent to a specialized lab for editing, a process that took about three months, according to Crawford.
In January, Weatherspoon began chemotherapy to destroy the damaged cells and make room for the newly edited cells. He felt tired. His hair fell out. He turned to video games like Fortnight and Grand Theft Auto to try and escape reality.
Finally, the time came to infuse the new cells into his body. For four weeks, he was monitored at Holtz to make sure everything went well and to keep him safe as his immune system recovered.
His twin brother, who had joined the U.S. Army, surprised him with a visit, just in time to watch the Super Bowl together. His girlfriend surprised him for Valentine's Day. Family members cycled in and out of his hospital room.
'To see people take time out of their day ... to come see me, that just means a lot,' said Weatherspoon.
After 45 days in the hospital, Weatherspoon was discharged. He's now back home in Sanford, part of Central Florida.
'He's doing extraordinarily well and the treatment was really perfect for him,' Crawford said. 'It's a complete change of his life and he really doesn't have sickle cell disease anymore and he's pretty much leading a normal life.'
Weatherspoon will need to visit Holtz monthly for monitoring and is taking penicillin for infection prevention. Clinical trial researchers will keep tabs on him for years.
He's also taking advantage of his new pain-free life.
Weatherspoon went ATV riding for his 21st birthday, without needing any pain medications. His crippling migraines are gone. He said he's been able to walk to the grocery store and come back home, for the first time ever, with no pain.
'I'm actually at a loss for words,' he said. 'My whole life just changed because everything I was doing before I could do it even better now. I'm not in pain every day.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Popular Kids' Cough Medicine Recalled for Risk of Bacterial Infection That 'Can Cause Death'
Medtech Products is recalling five lots of its Little Remedies Honey Cough Syrup for bacterial contamination The food-borne illness causes gastrointestinal symptoms, which can be mild in healthy individuals but can cause death with long exposure The recall also extends to any lots within expiryA popular cough medicine for children is being recalled for possible bacterial contamination. Medtech Products issued a voluntary recall of five lots of its Little Remedies Honey Cough Syrup due to "the presence of Bacillus cereus and loss of shelf-stability," the United States Food and Drug Administration stated in an announcement on June 18. The product was distributed nationwide between Dec. 14, 2022, and June 4, 2025. Bacillus cereus is a bacteria that can cause two kinds of foodborne illnesses, both related to gastrointestinal issues. The first illness is marked by nausea, vomiting and stomach cramps that begin anywhere from one to six hours after consuming the contaminated product. The second illness, which tends to begin eight to 16 hours after consuming the contaminated product, is marked by stomach cramps and diarrhea. "Although healthy individuals may suffer only short term illness, exposure to high levels of foodborne B. cereus can cause death," the announcement read. The recall extends to Little Remedies Honey Cough Syrup in a 4 fl oz amber bottle with a UPC of 7-56184-10737-9. The lots included in the recall are as follows: Lot 0039, with an expiration date of 11/2025 Lot 0545, with an expiration date of 01/2026 Lot 0640, with an expiration date of 02/2026 Lot 0450, with an expiration date of 05/2026 Lot 1198, with an expiration date of 12/2026 Furthermore, all lots of the product that are still within expiry are included in the recall. Customers who bought the recalled product are urged to stop using it immediately and contact a doctor in the event of any symptoms that could be associated with using the product. The company will also offer reimbursement to those who purchased items from the recalled lots. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories. Medtech Products did not disclose how it discovered the bacterial contamination. Any further questions or concerns should be directed to Medtech at medicalaffairs@ on their site, or by phone at (800) 754-8853. Read the original article on People
Yahoo
an hour ago
- Yahoo
Elon Musk Tries To Shut Down Drug Use Rumors With Negative Test Results, But Timeline Raises Eyebrows
Tech billionaire Elon Musk is shutting down allegations of drug use by posting his clean test results. Musk was seemingly prompted to share his result after a publication had claimed that he frequently used ketamine and psychedelics. While Elon Musk released the test results to discredit the drug claims, it has only further fueled more speculation, especially due to the short detection window. Musk fired back at The New York Times following their recent allegations of his "intense" drug use by posting drug test results showing he's clean across the board. On Tuesday, June 17, Musk shared a screenshot via X (formerly Twitter), captioning it with a simple "lol." The test, conducted by Fastest Labs of South Austin, lists "Elon Musk" as the donor and shows negative results for a range of substances, including ketamine, ecstasy, cocaine, and amphetamines. Notably, the test was taken on June 11, nearly two weeks after The Times published a report alleging that the former White House advisor frequently used ketamine and psychedelics while supporting Donald Trump's 2024 presidential campaign. While Musk shared the results as a rebuttal to The Times, its credibility as a rebuttal has been called into question. Fastest Labs' website notes a key limitation: "urine drug tests can detect drugs that have been ingested within the last 2-10 days." A clinic employee confirmed this to People Magazine, explaining that most substances exit the system quickly, except cannabis, which tends to linger longer. They also emphasized that hair follicle tests offer a much broader detection range, capable of identifying drug use dating back up to 90 days, making them a more reliable option for assessing long-term patterns of use. Reactions to Musk's drug test results have been mixed, with many expressing skepticism about the validity. One more person commented, "The richest man in the world does not have the resources to cheat a piss test? Give me a break." Another said, "Ketamine stays in your blood like 48h if you're a daily user, Mfer, you're not the first to game a drug test." A third person noted, "Now do the same test but with your hair.... a urine test only says you didn't have drugs the last couple of days." The New York Times also hit back at his post, writing, "Elon Musk is continuing to lash out because he doesn't like our reporting. Nothing that he's said or presented since our article about his drug use during the presidential campaign was published contradicts what we uncovered. We stand by our journalism." The test came in response to a May 30 New York Times article alleging Musk had been using ketamine frequently throughout 2024, to the point it was damaging his bladder. The claims surfaced as Musk ramped up financial and public support for Donald Trump's reelection campaign, donating nearly $275 million. The report also stated that Musk carried a pill box containing Adderall and used other psychedelics. During a joint press conference with Trump, Musk was asked about the Times' report. He dismissed the publication's credibility and told the reporter to "move on." Later, he reiterated via social media that he does not use drugs. Meanwhile, President Trump, speaking to reporters near Air Force One, said he wasn't aware of any drug use by Musk. "I'm not troubled by anything with Elon," he stated at the time. "I think he's fantastic." Meanwhile, Musk's relationship with President Trump has unraveled, coinciding with the end of his role as a "special government employee" on May 30, the same day The New York Times published its story on Musk's alleged drug use. In the days that followed, the tech billionaire launched into a social media offensive that severely strained his ties with the president. During the outburst, which spanned a few days, Musk harshly criticized Trump's proposed "One Big, Beautiful Bill," calling it a "disgusting abomination." He went further, claiming credit for Trump's 2024 election win and even accusing the president of concealing Jeffrey Epstein-related files to protect himself—an accusation Musk later deleted. On June 5, when asked to respond to Musk's online attacks, Trump expressed dismay. "Elon and I had a great relationship," he said, pointedly using the past tense. "I don't know if we will anymore." By June 11, Musk appeared to reconsider his remarks. In a post published on X around 3 a.m. ET, he admitted feeling "regret" and noted that some of his criticisms had "gone too far."
Yahoo
an hour ago
- Yahoo
SpaceX's Starship explodes in test, Musk calls it 'just a scratch'
June 19 (UPI) -- A SpaceX heavy-lift Starship launch vehicle exploded late Wednesday during a preflight procedure at Starbase in Texas as the company tested its upper stage. The company has not made public the cause of the explosion, and in a post on X, CEOI think Elon Musk called it "Just a scratch." The two-stage rocket exploded about 11 p.m. CDT Wednesday as it was preparing for its 10th flight, SpaceX said in a statement on X. Both X and SpaceX are owned by Elon Musk. The spaceship is composed of two reusable sections, the first-stage booster named Super Heavy and the upper-stage spacecraft known as Starship or just Ship. It was the Ship that exploded into a huge fireball while on a test stand at Starbase's Massey site. It was being tested to prepare for the Starship's upcoming 10th flight test. The Texas-based company said the Starship had "experienced a major anomaly." "A safety clear area around the site was maintained throughout the operation and all personnel are safe and accounted for," a statement said. The explosion happened during a static-fire test. That test briefly ignites rocket engines while the Starship is anchored to the ground. The explosion was the latest in a series of setbacks involving Starship upper stages. The Ship section broke apart during the last three Starship test flights in January, March and May 2025. SpaceX has not publicly released a launch date for a 10th Starship test flight. Video of the explosion posted online shows the spacecraft was on the ground when it exploded. The spacecraft is seen idling while steam and smoke billow around its base. Then, a large flash is seen followed by a huge fireball being ejected into the air. SpaceX said it was working with local authorities at the test site. "There are no hazards to residents in surrounding communities, and we ask that individuals do not attempt to approach the area while safing operations continue," it said.